The $ 38 billion US commercial weight loss market is 15% higher than in 2020, but it had to turn to adapt to the huge competition of popular GLP-1 drugs.
$38.4 Billion U.S. Commercial Weight Loss Market Pivots to Survive GLP-1 Drugs Explosion
Weight
$33.8 Billion U.S. Medical Weight Loss Market Now Dominated by GLP-1 Drugs
At one time, the history of the United States weight loss market has been dominated by a single product such as new GLP-1 weight loss drugs. US diets have come to them, avoiding commercial weight loss programs such as weight monitoring, mediifast, and retail and MLM meals.
The Most Popular New Year’s Resolution Isn’t Weight Loss
New year, new financial outlook? A recent Statista survey of 1,050 Americans singled out one New Year’s resolution above all others: saving more money. One in five US adults have decided to save more by 2025, making it the most popular goal overall. Meanwhile, 19% of adults decided to eat healthier, 17% to exercise more, … Read more